Key Takeaways BTSG is set to report Q4 2025 results on Feb. 27, with revenues seen at $3.35B and EPS at 34 cents.Pharmacy Solutions likely drove growth on specialty scripts, generics and new drug launches.BTSG may post stronger margins, aided by mix gains, cost control and seasonal strength.BrightSpring Health Services, Inc. (BTSG) is scheduled to release fourth-quarter 2025 results on Feb. 27, before market open. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 11.1 ...